The Control Pursuer

Mary age 45

“I want to lose weight, and I know it is up to me. I just need more willpower to control my impulses to eat. It is hard. Right now I feel stuck.”

Is Mysimba® right for Mary?

Not an actual patient.

Actor portrayal of Mary, the control pursuer potentially indicated for Mysimba®.

Medical Background

  • BMI of 33
  • Waist circumference: 43 in
  • Has hypertension, which is currently controlled with an ACE-inhibitor and hydrochlorothiazide
  • Has high cholesterol, which is currently managed with atorvastatin

Weight-loss History

  • Wants to lose weight but is overwhelmed by how to get started
  • Avoids talking with her doctor about her weight due to feeling ashamed
  • Continues to gain weight year after year, even though she goes on walks regularly
  • Seeks control over her impulsive eating

Lifestyle and Beliefs

  • A perfectionist and worrier who struggles with control in her life
  • Finds it difficult to manage her diet, eating, and urge to eat
  • Lacks the self-control to make smart choices with her eating habits
  • Frequently has feelings of regret or guilt after eating
  • Feels hopeless that a weight-loss solution will work because of past failures

Help patients like Mary regain control of their eating with Mysimba®1,2*

View another patient

BMI=body mass index.

ACE=angiotensin-converting enzyme.

*The exact neurochemical effects of Mysimba® leading to weight loss are not fully understood.1

References:

  1. Mysimba® (naltrexone HCl and bupropion HCl) [prescribing information]. Brentwood, TN: Nalpropion Pharmaceuticals LLC; 2021.
  2. Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes (Lond). 2015;39(8):1188-1196.
Reporting adverse effects: Adverse effects should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Alternatively you can report a suspected adverse drug reaction to the Yellow Card scheme by calling 0800 731 6789 Adverse events should also be reported to Orexigen®: +44 20 3966 0116 or currax.mi@primevigilance.com.
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014
Important Safety Information

Please refer to the Mysimba® Summary of Product Characteristics (SmPC)


▼ Black Triangle

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

MYS 014